Identification of gene pathways altered by deletion of the androgen receptor specifically in mineralizing osteoblasts and osteocytes in mice

Journal of Molecular Endocrinology

Volumn 49, Issue 1, 2012, Pages 1-10

  Russell, Patricia K ^a   Clarke, Michele V ^a   Skinner, Jarrod P ^a   Pang, Tammy P S ^a   Zajac, Jeffrey D ^a   Davey, Rachel A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANDROGEN; ANDROGEN RECEPTOR; COLLAGEN TYPE 1; DIPEPTIDYL PEPTIDASE IV; GROWTH HORMONE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; WNT4 PROTEIN;

ANDROGEN DEPRIVATION THERAPY; ANDROGEN THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MATRIX; BONE MINERALIZATION; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HORMONE RESPONSE; MALE; MICROARRAY ANALYSIS; MOUSE; MUSCULOSKELETAL DEVELOPMENT; NONHUMAN; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UPREGULATION;

ADIPONECTIN; ANDROGENS; ANIMALS; BLOOD GLUCOSE; CALCIFICATION, PHYSIOLOGIC; GENE DELETION; GENE EXPRESSION PROFILING; GENE TARGETING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; OSTEOBLASTS; OSTEOCYTES; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84863528643     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0014     Document Type: Article

References (46)

1. Abu EO, Horner A, Kusec V, Triffitt JT & Compston JE 1997 The localization of androgen receptors in human bone. Journal of Clinical Endocrinology and Metabolism 82 3493-3497. (doi:10.1210/jc. 82.10.3493)
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K et al. 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257 79-83. (doi:10.1006/bbrc.1999.0255)
3. Axell AM, MacLean HE, Plant DR, Harcourt LJ, Davis JA, Jimenez M, Handelsman DJ, Lynch GS & Zajac JD 2006 Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. American Journal of Physiology. Endocrinology and Metabolism 291 E506-E516. (doi:10.1152/ajpendo.00058.2006)
4. Baker AR, Hollingshead PG, Pitts-Meek S, Hansen S, Taylor R & Stewart TA 1992 Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice. Molecular and Cellular Biology 12 5541-5547. (doi:10.1128/MCB.12.12.5541)
5. Basaria S & Dobs AS 2001 Hypogonadism and androgen replacement therapy in elderly men. American Journal of Medicine 110 563-572. (doi:10.1016/S0002-9343(01)00663-5)
6. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U & Reseland JE 2004 Adiponectin and its receptors are expressed in bone-forming cells. Bone 35 842-849. (doi:10.1016/j.bone.2004.06.008)
7. Biason-Lauber A & Konrad D 2008 WNT4 and sex development. Sexual Development 2 210-218. (doi:10.1159/000152037)
8. Bonewald LF & Dallas SL 1994 Role of active and latent transforming growth factor beta in bone formation. Journal of Cellular Biochemistry 55 350-357. (doi:10.1002/jcb.240550312)
9. Chang J, Sonoyama W, Wang Z, Jin Q, Zhang C, Krebsbach PH, Giannobile W, Shi S & Wang CY 2007 Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. Journal of Biological Chemistry 282 30938-30948. (doi:10.1074/jbc. M702391200)
10. Chiang C, Chiu M, Moore AJ, Anderson PH, Ghasem-Zadeh A, McManus JF, Ma C, Seeman E, Clemens TL, Morris HA et al. 2009 Mineralization and bone resorption are regulated by the androgen receptor in male mice. Journal of Bone and Mineral Research 24 621-631. (doi:10.1359/jbmr.081217)
11. Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL & Spelsberg TC 1989 Identification of androgen receptors in normal human osteoblast-like cells. PNAS 86 854-857. (doi:10.1073/pnas.86.3.854)
12. Davey RA, Hahn CN, May BK & Morris HA 2000 Osteoblast gene expression in rat long bones: effects of ovariectomy and dihydrotestosterone on mRNA levels. Calcified Tissue International 67 75-79. (doi:10.1007/s00223001100)
13. Dohi O, Ohtani H, Hatori M, Sato E, Hosaka M, Nagura H, Itoi E & Kokubun S 2009 Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours. Histopathology 55 432-440. (doi:10.1111/j.1365- 2559.2009.03399.x)
14. Drucker DJ & Nauck MA 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368 1696-1705. (doi:10.1016/S0140- 6736(06)69705-5)
15. Franz-Odendaal TA, Hall BK & Witten PE 2006 Buried alive: how osteoblasts become osteocytes. Developmental Dynamics 235 176-190. (doi:10.1002/dvdy.20603)
16. Grossmann M, Gianatti EJ & Zajac JD 2010 Testosterone and type 2 diabetes. Current Opinion in Endocrinology, Diabetes & Obesity 17 247-256. (doi:10.1097/MED.0b013e32833919cf)
17. Harvey S 2010 Extrapituitary growth hormone. Endocrine 38 335-359. (doi:10.1007/s12020-010-9403-8)
18. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaisse JM & Foged NT 2002 Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. Journal of Biological Chemistry 277 44061-44067. (doi:10.1074/jbc.M207205200)
19. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT & Baylink DJ 1989 Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124 1576-1578. (doi:10.1210/endo-124- 3-1576)
20. Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T et al. 2003 Suppressive function of androgen receptor in bone resorption. PNAS 100 9416-9421. (doi:10.1073/pnas.1533500100)
21. Knabbe C, Klein H, Zugmaier G & Voigt KD 1993 Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 47 137-142. (doi:10.1016/0960-0760(93)90067-7)
22. Kyle KA, Willett TL, Baggio LL, Drucker DJ & Grynpas MD 2011 Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice. Endocrinology 152 457-467. (doi:10.1210/en.2010-1098)
23. Lanfranco F, Zitzmann M, Simoni M & Nieschlag E 2004 Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clinical Endocrinology 60 500-507. (doi:10.1111/j.1365-2265.2004.02007.x)
24. MacLean HE, Chiu WS, Ma C, McManus JF, Davey RA, Cameron R, Notini AJ & Zajac JD 2008 A floxed allele of the androgen receptor gene causes hyperandrogenization in male mice. Physiological Genomics 33 133-137. (doi:10.1152/physiolgenomics.00260.2007)
25. MacLean HE, Moore AJ, Sastra SA, Morris HA, Ghasem-Zadeh A, Rana K, Axell AM, Notini AJ, Handelsman DJ, Seeman E et al. 2010 DNA-binding-dependent androgen receptor signaling contributes to gender differences and has physiological actions in males and females. Journal of Endocrinology 206 93-103. (doi:10.1677/JOE-10- 0026)
26. Metzger DL & Kerrigan JR 1993 Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: evidence for independent actions of estrogen and androgen. Journal of Clinical Endocrinology and Metabolism 76 1147-1152. (doi:10.1210/jc.76.5.1147)
27. Notini AJ, Davey RA, McManus JF, Bate KL & Zajac JD 2005 Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model. Journal of Molecular Endocrinology 35 547-555. (doi:10.1677/jme.1.01884)
28. Notini AJ, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WS, Glatt V, Kream BE, Handelsman DJ, Morris HA et al. 2007 Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. Journal of Bone and Mineral Research 22 347-356. (doi:10.1359/jbmr.061117)
29. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H & Shimomura I 2005 Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochemical and Biophysical Research Communications 331 520-526. (doi:10.1016/j. bbrc.2005.03.210)
30. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB & Stein GS 1990 Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. Journal of Cellular Physiology 143 420-430. (doi:10.1002/jcp.1041430304)
31. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM & Bremner WJ 2005 Testosterone administration suppresses adiponectin levels in men. Journal of Andrology 26 85-92.
32. Payne AH & Hales DB 2004 Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine Reviews 25 947-970. (doi:10.1210/er.2003-0030)
33. Rana K, Fam BC, Clarke MV, Pang TP, Zajac JD & MacLean HE 2011 Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance. American Journal of Physiology. Endocrinology andMetabolism 301 E767-E778. (doi:10.1152/ajpendo. 00584.2010)
34. Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB & Roberts AB 1987 Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. Journal of Cell Biology 105 457-463. (doi:10.1083/jcb.105.1.457)
35. Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, Terauchi Y, Kadowaki T, Takeuchi Y, Fukumoto S et al. 2006 Regulation of bone formation by adiponectin through autocrine/ paracrine and endocrine pathways. Journal of Cellular Biochemistry 99 196-208. (doi:10.1002/jcb.20890)
36. Swarbrick MM & Havel PJ 2008 Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metabolic Syndrome and Related Disorders 6 87-102. (doi:10.1089/met.2007.0029)
37. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP & Bouillon R 1992 Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 130 2906-2916. (doi:10.1210/en.130.5.2906)
38. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R & Ohlsson C 2004 Androgens and bone. Endocrine Reviews 25 389-425. (doi:10.1210/er.2003-0003)
39. Venken K, De Gendt K, Boonen S, Ophoff J, Bouillon R, Swinnen JV, Verhoeven G & Vanderschueren D 2006 Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. Journal of Bone and Mineral Research 21 576-585. (doi:10.1359/jbmr.060103)
40. Wiren KM 2005 Androgens and bone growth: it's location, location, location. Current Opinion in Pharmacology 5 626-632. (doi:10.1016/j. coph.2005.06.003)
41. Wiren KM, Zhang XW, Toombs AR, Kasparcova V, Gentile MA, Harada S & Jepsen KJ 2004 Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals. Endocrinology 145 3507-3522. (doi:10.1210/en. 2003-1016)
42. Wiren KM, Semirale AA, Zhang XW, Woo A, Tommasini SM, Price C, Schaffler MB & Jepsen KJ 2008 Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton. Bone 43 440-451. (doi:10.1016/j.bone.2008.04.026)
43. Wong IP, Zengin A, Herzog H and Baldock PA 2008 Central regulation of bone mass. Seminars in Cell and Developmental Biology 19 452-458. (doi:10.1016/j.semcdb.2008.08.001)
44. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ et al. 2005 Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. Journal of Biological Chemistry 280 18073-18080. (doi:10.1074/jbc.M414231200)
45. Yarrow JF, Conover CF, Lipinska JA, Santillana CA, Wronski TJ & Borst SE 2010 Methods to quantify sex steroid hormones in bone: applications to the study of androgen ablation and administration. American Journal of Physiology. Endocrinology and Metabolism 299 E841-E847. (doi:10.1152/ajpendo.00384.2010)
46. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X et al. 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. PNAS 99 13498-13503. (doi:10.1073/pnas.212474399)